HuffPost Live interviews MAPS Founder Rick Doblin, PhD, David Nichols, PhD, and John Halpern, MD, about the recently published results from MAPS’ study of LSD-assisted psychotherapy to treat anxiety associated with advanced-stage illness. The experts speak about the variety of conditions that can potentially benefit from psychedelic-assisted therapy and share their perspectives on the past, present, and future of research in this area.
Originally appearing here.
The first LSD study conducted on patients in 40 years has revealed the drug has lasting therapeutic effects when it comes to anxiety. Should LSD be reconsidered in medical circles?